Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial
This study will provide evidence regarding medical therapy for AS patients who underwent TAVI and filling the gap in the Chinese population.Trial registrationChinese Clinical Trial RegistryChiCTR2100042266. Registered on 17 January 2021 (Source: Trials)
Source: Trials - July 18, 2021 Category: Research Source Type: clinical trials
Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions: Microalbuminuria; Cardiovascular Diseases; Renal Disease Interventions: Drug: Fosinopril; Drug: Pravastatin; Drug: Fosinopril Placebo; Drug: Pravastatin Placebo Sponsors: University Medical Center Groningen; Dutch Kidney Foundation; Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
Condition: Chronic Kidney DiseaseInterventions: Drug: Fosinopril; Drug: Benidipine; Drug: HydrochlorothiazideSponsors: Shanghai Changzheng Hospital; First Affiliated Hospital of Zhejiang University; Zhongda Hospital; Ruijin Hospital; The First Affiliated Hospital of Zhengzhou University; Sichuan Provincial People's Hospital; The Second Affiliated Hospital of Dalian Medical University; The First Affiliated Hospital of Anhui Medical UniversityNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2015 Category: Research Source Type: clinical trials
